Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
了解更多
From the Trenches: Expert Guidance for Molecular GI Testing
“Clinical and lab professionals share best practices, assay evaluations
If gastrointestinal pathogen testing is part of your job, don’t miss this informative webinar from two experts in the field. “Fecal Matters: Clinician and Laboratorian Perspective on Impact of Molecular GI Pathogen Testing” features speakers from clinical labs in Utah and North Carolina who offer case studies and helpful tips based on their experience…”
Continue Reading…
The team from Galapagos NV talks about their Mission to become the largest Biotech company in Europe, and how automating the Luminex FLEXMAP 3D® system is helping with their drug discovery.
Watch more videos >
July 24
Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay
July 17
Luminex Corporation Second Quarter Earnings Release Scheduled for August 7, 2017
June 28
Luminex Corporation Receives CE-IVD Mark for ARIES® Norovirus Assay
May 25
Luminex Corporation To Present At Jefferies 2017 Global Healthcare Conference
May 24
Luminex Corporation Declares Second Quarter Cash Dividend
Microbiology Meeting
31 August-1 September
Switzerland
MipTec
11-15 September
Basel, CH
20th Annual Meeting of the European Society for Clinical Virology
13-16 September
Stresa, IT
16th Human Proteome Organisation World Congress
17-21 September
Dublin, IR
xMAP Connect EU 2017
8-9 November
Amsterdam, NL
